Tacrolimus/BSA is an antigen-adjuvant conjugate of Tacrolimus with bovine serum albumin (BSA). Conjugating the antigen with a protein adjuvant enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or disrupt major epitopes and can enhance cross-presentation and the generation of antigen-specific T cells.